Cytiva, now with the life sciences business from Pall Corporation, is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients.
Visit cytiva.com to learn more.
|
|
|
|
|
5,001-10,000 employees
View all Cytiva employees
|
|
|
Biotechnology
|
|
|
$1B–$5B
|
|
|
+1 800-522-4032
|
|
|
Global, Global 000000, OO
|
|
|
None
|
|
|
Biotechnology, Molecular Biology, Bioprocess, Cell Therapy, Gene Therapy, Bioprocess, Mrna, Cell Therapy, Lab Filtration, Gene Therapy
|
Emmanuel Ligner is the CEO of Cytiva. To contact Emmanuel Ligner email at [email protected].
The decision makers in Cytiva are Ludovic Brellier, Bruno Balod, Christopher Riley, etc. Click to Find Cytiva decision makers emails.
Cytiva headquarters is located at Global, Global 000000, OO.
Cytiva generates an estimated $1B–$5B annually, based on industry analysis and publicly available market data.
You can contact Cytiva by calling +1 800-522-4032.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.